titanium has been researched along with Peritoneal Carcinomatosis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Imano, M; Okuno, K | 1 |
Goto, S; Kamigaki, T; Saito, M; Yano, K | 1 |
Abe, H; Fujie, Y; Fujita, J; Fujita, S; Hashimoto, K; Imaoka, S; Monden, T; Nishida, K; Ohnishi, T; Tono, T; Yanagawa, T; Yoshida, T | 1 |
Kinoshita, H; Kitaura, T; Nakae, S; Onoyama, H; Sainoh, K; Saitoh, Y; Shiroiwa, H; Sugihara, S; Takahashi, T; Takao, S; Toyota, J; Urakawa, T; Yamamoto, M | 1 |
Aoki, T; Hibi, Y; Hoshino, S; Ito, K; Katayanagi, S; Suda, T; Sudo, H; Takagi, Y; Tsuchida, A | 1 |
Kawaguchi, A; Yamaguchi, S; Yoshida, K | 1 |
Rosen, DM; Sutton, CJ | 1 |
1 review(s) available for titanium and Peritoneal Carcinomatosis
Article | Year |
---|---|
Treatment strategies for gastric cancer patients with peritoneal metastasis.
Topics: Antibodies, Bispecific; Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion Molecules; Clinical Trials, Phase II as Topic; Epithelial Cell Adhesion Molecule; Humans; Infusions, Parenteral; Molecular Targeted Therapy; Paclitaxel; Peritoneal Neoplasms; Prognosis; Receptor, ErbB-2; Silicates; Stomach Neoplasms; Survival Rate; Titanium | 2014 |
6 other study(ies) available for titanium and Peritoneal Carcinomatosis
Article | Year |
---|---|
A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA).
Topics: Adenocarcinoma, Scirrhous; Adult; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Signet Ring Cell; Cisplatin; Combined Modality Therapy; Dichloroacetic Acid; Docetaxel; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hyperthermia, Induced; Irinotecan; Ovarian Neoplasms; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Photosensitizing Agents; Prognosis; Silicates; Stomach Neoplasms; Taxoids; Tegafur; Titanium | 2013 |
[Adjuvant therapy with WT1 peptide-pulsed dendritic cell therapy in combination with TS-1 for pancreatic cancer with positive peritoneal cytology after curative operation].
Topics: Aged; Cancer Vaccines; Chemotherapy, Adjuvant; Combined Modality Therapy; Dendritic Cells; Female; Humans; Immunotherapy; Pancreatectomy; Pancreatic Neoplasms; Peptides; Peritoneal Neoplasms; Silicates; Titanium; WT1 Proteins | 2014 |
[A patient with peritoneal metastasis from gastric cancer who responded to weekly chemotherapy with paclitaxel on the third line and could take meal].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Humans; Irinotecan; Male; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Silicates; Stomach Neoplasms; Titanium | 2003 |
[Long survival and effective treatment of unresectable gastric cancer by TS-1 based chemotherapy with a sequential combination].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Peritoneal Neoplasms; Quality of Life; Silicates; Stomach Neoplasms; Survivors; Taxoids; Titanium | 2007 |
[A case of scirrhous gastric cancer with peritoneal metastases successfully treated by combined chemotherapy of biweekly paclitaxel and TS-1 followed by curative resection].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Routes; Gastrectomy; Humans; Lymph Node Excision; Male; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Silicates; Stomach Neoplasms; Titanium | 2007 |
Use of the potassium titanyl phosphate (KTP) laser in the treatment of benign multicystic peritoneal mesothelioma.
Topics: Adult; Female; Humans; Laser Therapy; Mesothelioma, Cystic; Peritoneal Neoplasms; Phosphates; Titanium | 1999 |